JG
HRMY icon

Jain Global’s Harmony Biosciences HRMY Stock Holding History

Jain Global’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+41,235
New +$1.3M 0.01% 858

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's HRMY Position: Q2 2026 in Review

Jain Global opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 41,235 shares worth $1.5M. The stake represents 0.01% of the portfolio and ranks #858 among its holdings.

326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jain Global held 41,235 shares of Harmony Biosciences worth $1.5M as of Q2 2026.
  • Harmony Biosciences was a new Jain Global position in Q2 2026.
  • Harmony Biosciences made up 0.01% of Jain Global's portfolio in Q2 2026, its #858 holding.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.